Israel's SciVac eyes global expansion of 3G hepatitis B vaccine

An article from Reuters
July 25, 2013
Israel's SciVac eyes global expansion of 3G hepatitis B vaccine

 

July 25, 2013--SciVac, an Israeli pharmaceutical company, has applied to the U.S. Food and Drug Administration for distribution of its hepatitis B vaccine in the United States. The vaccine, Sci-B-Vac, is given to the majority of Israeli children at birth. Sci-B-Vac is already registered for use in several countries in Asia and Africa, and according to the company's chief executive, Michal Ben-Attar, they are preparing to sign a distribution agreement for the vaccine in India. Read more on this story here.

Common Disease Taxonomy: 
Common Vaccine Taxonomy: